1. Abra RM, Hunt CA (1981) Liposome disposition in vivo: III.Dose and vesicle size effects. Biochim Biophys Acta 666: 493
2. Balazsovits JAE, Mayer LD, Bally MB, Cullis PR, Ginsberg RS, Falk RE (1989) Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol 23: 81
3. Bally MB, Nayar R, Masin D, Hope MJ, Cullis PR, Mayer LD (1990) Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta 1023: 133
4. Cowens JW, Kanter P, Brenner DE, Ginsberg RS, Mayer LD, Bally MB, Cullis PR, Pravalic Z, Douglass H, Petrelli N, Karakousis C, Creaven PJ (1989) Phase I study of doxorubicin encapsulated in liposomes. Am Soc Clin Oncol 8: A268
5. Finkelstein MC, Kuhn SH, Schieren H, Weissman G, Hoffstein S (1981) Liposome uptake by human leukocytes. Biochim Biophys Acta 673: 286